MedWatch

Coloplast considers increasing tax payment transparency after criticism

Following bouts of criticism from major Danish pension funds, medtech giant Coloplast reviews options for increasing transparency of tax payment.

Coloplast's EVP and CFO Anders Lonning Skovgaard | Photo: Coloplast / PR

A host of pension companies have called for more transparency in tax payments from major Danish companies – including Coloplast – the latter of which will examine the possibility of providing more transparency in the tax payment area, which Coloplast's Executive Vice President and Chief Financial Officer Anders Lonning Skovgaard confirms.

"They are calling for more transparency concerning our taxes, and we are working on exactly that. We're examining how to make our tax payments even more transparent to our stakeholders," the CFO tells MedWatch.

Read the whole article

Get 14 days free access.
No credit card required.

An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP recommends nine new drugs, rejects one

Roche and Biogen are among the companies that have received recommendation for approval from the European Medicines Agency's committee (CHMP) at its September meeting. One Pfizer drug was the sole candidate to be rejected.

CEO at WSA: No clarity on EQT exit plans yet

The time horizon for the venture fund EQT's investment in WS Audiology should be ending soon, but according to Group CEO Eric Bernard, there is no clarity on when the potential changes might occur.

Further reading

Related articles

Trial banner

Latest news

See all jobs